P1133: CHIDAMIDE PLUS PREDNISONE, CYCLOPHOSPHAMIDE, AND THALIDOMIDE (CPCT) FOR RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA: A MULTICENTER PHASE II TRIAL

• Jinhua Liang,
• LI Wang,
• Xiao-Dong Wang,
• Guohui Cui,
• Jian-Feng Zhou,
• Jing-Yan Xu,
• Luqun Wang,
• Rong Liang,
• Bi-Yun Chen,
• Jian Cheng,
• Jianyong LI,
• Wei Xu

Affiliations

Jinhua Liang

1 the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Hematology, Nanjing, China

LI Wang

1 the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Hematology, Nanjing, China

Xiao-Dong Wang

2 Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospita, School of Medicine of University of Electronic Science and Technology of China

Guohui Cui

3 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Jian-Feng Zhou

4 Tong Ji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Jing-Yan Xu

5 Nanjing Drum Tower Hospital, Nanjing University Medical School

Luqun Wang

6 Qilu Hospital of Shandong University

Rong Liang

7 Xijing Hospital, The Fourth Military Medical University

Bi-Yun Chen

8 Fujian Provincial Hospital

Jian Cheng

9 Zhongda Hospital, Medical School of Southeast University

Jianyong LI

10 the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital

Wei Xu

10 the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital